Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
296 studies found for:    leukemia AND (women OR woman OR female)
Show Display Options
Rank Status Study
21 Completed Collection and Banking of Leukemia Cells MDS/AML
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia
Intervention: Other: Collection of Leukemia Cells
22 Completed A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies
Conditions: Lymphoma, Mantle-cell;   Leukemia, Lymphocytic, Chronic, B-Cell;   Leukemia, Hairy Cell;   Waldenstrom Macroglobulinemia;   Multiple Myeloma
Intervention: Drug: ON01910 Na
23 Completed GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
Conditions: Myelodysplastic Syndrome RAEB-I or RAEB-II;   Refractory Acute Myeloid Leukemia;   Refractory CML Myeloid Blast Crisis
Intervention: Biological: GM-CSF secreting leukemia vaccine
24 Completed A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: All-trans retinoic acid;   Drug: Bryostatin 1
25 Completed Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1
Condition: Human T-Lymphoma Virus Type I
Intervention:
26 Completed High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML)
Condition: Acute Myelogenous Leukemia
Interventions: Drug: cytosine arabinoside (ara-C);   Drug: daunomycin;   Drug: interleukin-2
27 Terminated Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
Conditions: Acute Myeloid Leukemia;   Chronic Myelomonocytic Leukemia;   Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts
Intervention: Biological: GM-K562/leukemia cell vaccine
28 Completed Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Gleevec
29 Active, not recruiting Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Conditions: Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndrome
Intervention: Other: Questionnaires, Laboratory tests, Abdominal MRI
30 Completed Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Condition: Myelogenous Leukemia, Acute
Intervention: Drug: gefitinib
31 Active, not recruiting Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: GM-K562 vaccine;   Procedure: stem cell transplantation
32 Completed Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination
Condition: Cervical Cancer
Intervention: Drug: Licensed quadrivalent HPV vaccine, Gardasil
33 Completed
Has Results
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
Conditions: Leukemia, Lymphoblastic, Acute;   Osteoporosis
Interventions: Drug: Calcium carbonate (Tums), vitamin D;   Other: Placebo
34 Unknown  Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Condition: Refractory TdT-Positive Leukemia
Intervention: Drug: Cordycepin plus Pentostatin
35 Completed Lactation Outcomes Among Survivors of Pediatric Cancer
Conditions: Cancer;   Leukemia
Intervention: Other: Survey
36 Recruiting Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
Condition: Solid Tumor
Interventions: Drug: Bevacizumab;   Drug: Cyclophosphamide;   Drug: Valproic Acid;   Drug: Temsirolimus
37 Recruiting The Effect of Human Placental Explants and Pregnant Women Sera on Cancer Cells
Condition: Cancer
Intervention:
38 Active, not recruiting Alisertib for Acute Myeloid Leukemia
Condition: Acute Myelogenous Leukemia
Interventions: Drug: Cytarabine;   Drug: Idarubicin;   Drug: Alisertib
39 Completed RCT on the Effect of Endometrial Injury on Ongoing Pregnancy Rate in Subfertile Women Undergoing IVF
Condition: Subfertility
Intervention: Procedure: Endometrial aspiration by pipelle
40 Completed
Has Results
Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasms
Intervention: Drug: Pegylated L-Asparaginase

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.